Literature DB >> 23466915

Electronic health record-based detection of risk factors for Clostridium difficile infection relapse.

Courtney Hebert1, Hongyan Du, Lance R Peterson, Ari Robicsek.   

Abstract

OBJECTIVE: A major challenge in treating Clostridium difficile infection (CDI) is relapse. Many new therapies are being developed to help prevent this outcome. We sought to establish risk factors for relapse and determine whether fields available in an electronic health record (EHR) could be used to identify high-risk patients for targeted relapse prevention strategies.
DESIGN: Retrospective cohort study.
SETTING: Large clinical data warehouse at a 4-hospital healthcare organization. PARTICIPANTS: Data were gathered from January 2006 through October 2010. Subjects were all inpatient episodes of a positive C. difficile test where patients were available for 56 days of follow-up.
METHODS: Relapse was defined as another positive test between 15 and 56 days after the initial test. Multivariable regression was performed to identify factors independently associated with CDI relapse.
RESULTS: Eight hundred twenty-nine episodes met eligibility criteria, and 198 resulted in relapse (23.9%). In the final multivariable analysis, risk of relapse was associated with age (odds ratio [OR], 1.02 per year [95% confidence interval (CI), 1.01-1.03]), fluoroquinolone exposure in the 90 days before diagnosis (OR, 1.58 [95% CI, 1.11-2.26]), intensive care unit stay in the 30 days before diagnosis (OR, 0.47 [95% CI, 0.30-0.75]), cephalosporin (OR, 1.80 [95% CI, 1.19-2.71]), proton pump inhibitor (PPI; OR, 1.55 [95% CI, 1.05-2.29]), and metronidazole exposure after diagnosis (OR, 2.74 [95% CI, 1.64-4.60]). A prediction model tuned to ensure a 50% probability of relapse would flag 14.6% of CDI episodes.
CONCLUSIONS: Data from a comprehensive EHR can be used to identify patients at high risk for CDI relapse. Major risk factors include antibiotic and PPI exposure.

Entities:  

Mesh:

Year:  2013        PMID: 23466915     DOI: 10.1086/669864

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  17 in total

Review 1.  Recurrent Clostridium difficile infection: From colonization to cure.

Authors:  Kelsey Shields; Roger V Araujo-Castillo; Thimmaiah G Theethira; Carolyn D Alonso; Ciaran P Kelly
Journal:  Anaerobe       Date:  2015-04-27       Impact factor: 3.331

2.  Clostridium difficile infection in older adults.

Authors:  Robin Lp Jump
Journal:  Aging health       Date:  2013-08-01

3.  Acid Suppression Medications During Hospitalization as a Risk Factor for Recurrence of Clostridioides difficile Infection: Systematic Review and Meta-analysis.

Authors:  Palna Mehta; Ronald G Nahass; Luigi Brunetti
Journal:  Clin Infect Dis       Date:  2021-07-01       Impact factor: 9.079

Review 4.  Association of Gastric Acid Suppression With Recurrent Clostridium difficile Infection: A Systematic Review and Meta-analysis.

Authors:  Raseen Tariq; Siddharth Singh; Arjun Gupta; Darrell S Pardi; Sahil Khanna
Journal:  JAMA Intern Med       Date:  2017-06-01       Impact factor: 21.873

Review 5.  Opportunities and challenges in developing risk prediction models with electronic health records data: a systematic review.

Authors:  Benjamin A Goldstein; Ann Marie Navar; Michael J Pencina; John P A Ioannidis
Journal:  J Am Med Inform Assoc       Date:  2016-05-17       Impact factor: 4.497

6.  Prediction of Recurrent Clostridium Difficile Infection Using Comprehensive Electronic Medical Records in an Integrated Healthcare Delivery System.

Authors:  Gabriel J Escobar; Jennifer M Baker; Patricia Kipnis; John D Greene; T Christopher Mast; Swati B Gupta; Nicole Cossrow; Vinay Mehta; Vincent Liu; Erik R Dubberke
Journal:  Infect Control Hosp Epidemiol       Date:  2017-08-24       Impact factor: 3.254

7.  Strategies for handling missing clinical data for automated surgical site infection detection from the electronic health record.

Authors:  Zhen Hu; Genevieve B Melton; Elliot G Arsoniadis; Yan Wang; Mary R Kwaan; Gyorgy J Simon
Journal:  J Biomed Inform       Date:  2017-03-16       Impact factor: 6.317

8.  Magnitude and direction of the association between Clostridium difficile infection and proton pump inhibitors in adults and pediatric patients: a systematic review and meta-analysis.

Authors:  Tadayuki Oshima; Liping Wu; Min Li; Hirokazu Fukui; Jiro Watari; Hiroto Miwa
Journal:  J Gastroenterol       Date:  2017-07-25       Impact factor: 7.527

Review 9.  Fidaxomicin in Clostridium difficile infection: latest evidence and clinical guidance.

Authors:  Kathleen Mullane
Journal:  Ther Adv Chronic Dis       Date:  2014-03       Impact factor: 5.091

10.  Quality Outcomes in the Surgical Intensive Care Unit after Electronic Health Record Implementation.

Authors:  V H Flatow; N Ibragimova; C M Divino; D S A Eshak; B C Twohig; A M Bassily-Marcus; R Kohli-Seth
Journal:  Appl Clin Inform       Date:  2015-10-07       Impact factor: 2.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.